7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 13–16 November 2005, Dublin, Ireland

VISCERAL FAT-MASS IN 175 HAART-TREATED HIV-INFECTED PATIENTS

I Poizot–Martin¹, C Marimoutou¹, D Di Stephano², M-P Drogoul-Vey¹, K Djemli^1,3, P Vague³ and J-A Gastaut^1
1 CISIH-Sud Unité de Jour Hématologie-VIH, Département de Recherche Clinique, Hôpital Sainte-Marguerite, University Hospital of Marseilles, Marseilles, France; ² Service d’Imagerie Médicale, Institut Paoli-Calmettes, Marseilles, France; ³ Département de Nutrition-Endocrinologie-Maladies Métaboliques, Hôpital La Timone University Hospital of Marseilles, Marseilles, France

Antiviral Therapy 2005; Supplement 3:L22 (abstract no. 31)

BACKGROUND: It has been established that visceral fat accumulation is highly associated with the risk of insulin resistance and cardiovascular disease.

OBJECTIVES: To evaluate the visceral fat mass and metabolic profile (glucid/lipid) in 175 HAART-treated HIV-infected patients with clinical lipodystrophy.

METHODS: Cross-sectional study. Clinical lipodystrophy was classified as atrophy in case of subcutaneous fat loss without central fat accumulation; hypertrophy for central fat accumulation and/or or lipomatosis without atrophy and mixed type for patients presenting both characteristics. CT measured visceral abdominal (VAT) and subcutaneous adipose tissues (SAT) at the level of the L4–L5 intervertebral disc space and the subcutaneous fat at mid-thigh. Glucose metabolism was evaluated with oral glucose tolerance test (OGTT).

RESULTS: Patients were 38.9% females, mean aged 40 years with a median BMI of 22.3 (16.6% BMI >26). Their median CD4 cell count was 430/mm³, HIV–infection duration: 9.1 years, ART exposure: 5.1 years, current ART exposure: 1 year [30.9% receiving NNRTI and 68.6% PI] and 58.9% were HIV-RNA <400 copies/ml. Clinical lipodystrophy was 18.9% atrophy, 18.3% hypertrophy and 55.4% mixed syndrome. The median waist-tohip ratio was 0.94 [IQ: 0.90–0.99]. Mean VAT was 127.7 ±72.2 and SAT 99.2 ±73.9. There was a significant correlation between VAT measurements and waist-to-hip ratio, BMI, sex and age but not with ART exposure duration. OGTT results showed that 26.3% of patients present insulin resistance (IR), 10.9% diabetes, 12.6% trouble in glucose tolerance (TGT), 13.7% both IR and TGT, 36.6% were normal. VAT significantly increased from normal OGTT (mean 97.4 ±58.9) to IR (mean: 127.2 ±69.5) or TGT (mean 134.5 ±79) then to IR with TGT (mean 173.5 ±67.2) and diabetes (mean 164.8 ±74.3).

CONCLUSIONS: These HAART-treated patients presented a CT-measured high VAT significantly associated to the insulin resistance profile. VAT was correlated with the waist-to-hip ratio. These elements highlight the cardiovascular risk for HAART-treated patients with lipodystrophy, arguing for a rapid specific cardio-vascular management of such patients.

Download PDF of this abstract.

2005-11-13
31

Copyright © 2005 - International Medical Press Ltd. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Medical Editor, International Medical Press, 36 St Mary-at-Hill, London EC3R 8DU, United Kingdom.